Development

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.

Delivering the Goods

Gayatri C.Patel, M.Pharm, PhD, is associate professor in the Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy at the Charotar University of Science and Technology, Changa Campus, Changa- 388 421, Anand, Gujarat, India, gayatripatel.ph@charusat.ac.in, +91 2697 265162.

Research examined the effects of varying excipient and polymer weight in coatings designed to optimize the release of diclofenac sodium. The goal was to release it at night to improve the treatment of rheumatoid arthritis. 


Optimizing Compression Coating for Pulsatile Release Tablets

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

PATH’s Microarray Patch Center of Excellence aims to accelerate transdermal patch technology for public health needs.

Advancing Transdermal Drug Delivery

Cure Pharmaceutical secured a patent that lets the company load higher drug amounts to its proprietary drug delivery system, CUREfilm.

CURE Pharmaceutical Receives Patent for Oral Thin Film Technology

Wearable and smart devices allow user-friendly subcutaneous drug delivery.

Putting Drug Delivery into Patients’ Hands

Regulatory, cultural, and technical differences between drug and device development can pose challenges to pharmaceutical combination product development.

What Pharma Needs to Understand About Combination Product Development

Intertek has announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, UK, through the acquisition of a new 20,000 sq. ft facility.


Intertek Expands Pharma Services Facility

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Understanding the API, delivery mechanism, and excipient functionality is essential to solving drug solubility challenges.


Strategic Screening for Solubility Solutions

STA Pharmaceuticals and BioLingus have announced the formation of an exclusive technology and marketing collaboration for sublingual delivery.


Exclusive Agreement Forms for Sublingual Delivery

Transdermal patch design, materials, and manufacturing variables, as well as drug formulation and interactions between the API and the adhesive, can affect adhesion and drug delivery. 

Formulation and Drug Delivery, Specialty Dosage Forms